Month: December 2021

Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine

Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…

Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th

TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…

Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy

– DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to…

Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan

NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to…

SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline

PPF Group provides funding to advance SOTIO through key clinical milestones Proceeds shall be used…

Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…

Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow

BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…

Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances

Simcyp Simulator has been used to inform more than 250 label claims for 85+ novel…

Replimune Appoints Christy Oliger to its Board of Directors

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…

Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies

Visionary technology investor Samuel Chen to join Board of Directors ALAMEDA, Calif., Dec. 02, 2021…

GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program

Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S….

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting

SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…

Psyence Group Functional Mushroom Brand “GOODMIND™” Commences National Roll-Out in South Africa’s Largest Coffee Retail Chain

Company Broadens Revenue Generation Initiatives GOODMIND™ Elevate your daily grind / GOODMIND™ TORONTO, Dec. 02,…

Month: December 2021

Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine

Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th

Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy

Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan

SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline

Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow

Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances

Replimune Appoints Christy Oliger to its Board of Directors

Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies

GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting

Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe

Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products

Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

Better Choice to Participate at the 10th Annual ROTH Deer Valley Corporate Access Event on Thursday, December 9th

Launch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care

Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results

Plus Therapeutics to Present at MedInvest Oncology Investor Conference

Psyence Group Functional Mushroom Brand “GOODMIND™” Commences National Roll-Out in South Africa’s Largest Coffee Retail Chain

You may have missed

First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development

Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results

Fab-Form Industries Ltd Announces Patent for a Method of Installing and Supporting a Fabric Column Form

Coloured Ties Capital Inc. Provides Update on Canada Postal Strike and Voting at the Company’s 2024 Annual General Meeting

Worksport Increases Production Capacity to Meet Growing Sales Demand